-+ 0.00%
-+ 0.00%
-+ 0.00%

JIANGSU HENGRUI PHARMACEUTICALS <600276.SS> SAYS ITS SHR-4375 INJECTION FOR PANCREATIC CANCER GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA

Reuters·07/27/2026 08:44:25

Please log in to view news